|
Re: Report of exempt distribution
|
2
|
Resverlogix Corp.
|
Nov 10, 2020 05:27PM
|
|
Re: Renal trial delayed (again)
|
4
|
Resverlogix Corp.
|
Sep 28, 2017 02:21AM
|
|
Re: Renal trial delayed (again)
|
4
|
Resverlogix Corp.
|
Sep 28, 2017 11:13AM
|
|
Re: Renal and Fabry trial listings updated on ClinicalTrials.gov
|
5
|
Resverlogix Corp.
|
Apr 21, 2018 04:32PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
3
|
Resverlogix Corp.
|
Dec 05, 2019 08:47PM
|
|
Re: Remembering Relypsa
|
6
|
Resverlogix Corp.
|
Nov 30, 2018 02:34AM
|
|
Re: ReCvr
|
2
|
Resverlogix Corp.
|
Sep 25, 2017 02:58PM
|
|
Re: Recent publications:
|
3
|
Resverlogix Corp.
|
Sep 27, 2023 03:28PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
4
|
Resverlogix Corp.
|
Mar 23, 2020 02:28PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 05:48PM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
2
|
Resverlogix Corp.
|
Jul 16, 2019 12:43PM
|
|
Re: Rebuys start at $2.28
|
4
|
Resverlogix Corp.
|
Aug 09, 2018 06:31PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 01:25PM
|
|
Re: Reading The Tea Leaves
|
1
|
Resverlogix Corp.
|
May 31, 2017 12:19PM
|
|
Re: Re-jigging the matrix with Third Eye's involvement
|
5
|
Resverlogix Corp.
|
Apr 12, 2018 05:42PM
|
|
Re: Re-jigging the matrix with Third Eye's involvement
|
4
|
Resverlogix Corp.
|
Apr 12, 2018 06:13PM
|
|
Re: Re San fran
|
1
|
Resverlogix Corp.
|
Oct 20, 2020 04:24AM
|
|
Re: Re San fran
|
1
|
Resverlogix Corp.
|
Oct 20, 2020 04:31AM
|
|
Re: Re San fran
|
3
|
Resverlogix Corp.
|
Oct 20, 2020 04:52AM
|
|
Re: Re NR
|
3
|
Resverlogix Corp.
|
Apr 14, 2021 02:56PM
|
